1. Home
  2. OKYO vs COE Comparison

OKYO vs COE Comparison

Compare OKYO & COE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OKYO Pharma Limited

OKYO

OKYO Pharma Limited

SELL

Current Price

$1.09

Market Cap

78.2M

Sector

Health Care

ML Signal

SELL

Logo 51Talk Online Education Group

COE

51Talk Online Education Group

SELL

Current Price

$10.05

Market Cap

67.0M

Sector

Real Estate

ML Signal

SELL

Company Overview

Basic Information
Metric
OKYO
COE
Founded
2007
2011
Country
United Kingdom
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
78.2M
67.0M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
OKYO
COE
Price
$1.09
$10.05
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $8.33
N/A
AVG Volume (30 Days)
★ 282.3K
18.8K
Earning Date
07-20-2026
12-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$70.66
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.00
$9.93
52 Week High
$3.20
$42.99

Technical Indicators

Market Signals
Indicator
OKYO
COE
Relative Strength Index (RSI) 33.79 39.17
Support Level N/A $9.95
Resistance Level $1.70 $12.55
Average True Range (ATR) 0.13 0.60
MACD -0.03 -0.04
Stochastic Oscillator 20.23 18.29

Price Performance

Historical Comparison
OKYO
COE

About OKYO OKYO Pharma Limited

OKYO Pharma Ltd is a clinical-stage ophthalmology company focused on developing differentiated therapies for corneal and anterior segment diseases. It is advancing a pipeline designed to improve outcomes for patients suffering from debilitating ocular diseases that impact vision and ocular comfort. The company's main program, urcosimod, is being developed as a potential treatment for neuropathic corneal pain. Additionally, its development pipeline includes an exploratory candidate, OK-201, a non-opioid analgesic drug candidate, as a potential drug to treat acute and chronic ocular pain. The company has only one operating segment: the research and development of biotechnological and pharmaceutical products.

About COE 51Talk Online Education Group

51 Talk Online Education Group is an online education platform in China, with core expertise in English education. The company's mission is to make quality education accessible and affordable. It's online and mobile education platforms enable students across China to take live interactive English lessons with overseas foreign teachers, on demand. The Group operates in geographical areas: Asia-Pacific region; and Other areas, of which it derives maximum revenue from Asia-Pacific.

Share on Social Networks: